News & Updates
Filter by Specialty:
RA remission rates higher with abatacept, certolizumab pegol vs conventional therapy
17 Jul 2023
In the treatment of rheumatoid arthritis (RA), more patients achieve clinical remission with abatacept or certolizumab pegol, but not with tocilizumab, than with active conventional therapy, according to a study.
RA remission rates higher with abatacept, certolizumab pegol vs conventional therapy
17 Jul 2023
SGLT2 inhibitors tied to kidney benefits, reduced MACE risk
17 Jul 2023
byStephen Padilla
Treatment with sodium-glucose lowering co-transporter 2 inhibitors (SGLT2i) helps arrest the decline in estimated glomerular filtration rate (eGFR) and is associated with a lower risk of adverse kidney events among adults with diabetes, irrespective of baseline albuminuria status, as shown in a study presented at the recent ADA 2023.
SGLT2 inhibitors tied to kidney benefits, reduced MACE risk
17 Jul 2023
Meal replacement trumps food-based diet for improving CV risk factors in obese adults
17 Jul 2023
byAudrey Abella
In the secondary and exploratory analyses of the OPTIWIN trial, meal replacement (MR) outdid a food-based (FB) regimen in improving cardiometabolic risk in adults with obesity.
